solifenacin succinate has been researched along with clenbuterol in 1 studies
Studies (solifenacin succinate) | Trials (solifenacin succinate) | Recent Studies (post-2010) (solifenacin succinate) | Studies (clenbuterol) | Trials (clenbuterol) | Recent Studies (post-2010) (clenbuterol) |
---|---|---|---|---|---|
522 | 194 | 343 | 1,506 | 89 | 370 |
Protein | Taxonomy | solifenacin succinate (IC50) | clenbuterol (IC50) |
---|---|---|---|
Beta-2 adrenergic receptor | Homo sapiens (human) | 0.6705 | |
Beta-1 adrenergic receptor | Homo sapiens (human) | 0.12 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 2.652 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 2.652 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Trivedi, D | 1 |
1 review(s) available for solifenacin succinate and clenbuterol
Article | Year |
---|---|
Cochrane Review Summary: Pelvic floor muscle training added to another active treatment versus the same active treatment alone for urinary incontinence in women.
Topics: Clenbuterol; Combined Modality Therapy; Duloxetine Hydrochloride; Electric Stimulation; Exercise Therapy; Female; Hot Temperature; Humans; Mandelic Acids; Patient Satisfaction; Pelvic Floor; Solifenacin Succinate; Treatment Outcome; Urinary Incontinence; Urological Agents | 2015 |